Loading…

Acceptability of lopinavir/r pellets (minitabs), tablets and syrups in HIV-infected children

Lopinavir/ritonavir 'pellets' were recently tentatively approved for licensing. We describe their acceptability for infants and children up to 48 weeks. CHAPAS-2 was a randomized, two-period crossover trial comparing syrup and pellets in HIV-infected infants (n=19, group A, aged 3-

Saved in:
Bibliographic Details
Published in:Antiviral therapy 2016-01, Vol.21 (7), p.579-585
Main Authors: Kekitiinwa, Adeodata, Musiime, Victor, Thomason, Margaret J, Mirembe, Grace, Lallemant, Marc, Nakalanzi, Sarah, Baptiste, David, Walker, A Sarah, Gibb, Diana M, Judd, Ali
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Lopinavir/ritonavir 'pellets' were recently tentatively approved for licensing. We describe their acceptability for infants and children up to 48 weeks. CHAPAS-2 was a randomized, two-period crossover trial comparing syrup and pellets in HIV-infected infants (n=19, group A, aged 3-
ISSN:1359-6535
2040-2058
DOI:10.3851/IMP3054